Anti-SNRPN Polyclonal Antibody from ProteoGenix; catalogue ARO-A22065; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Anti-SNRPN Polyclonal Antibody: A Powerful Tool for Epigenetic Research
The Anti-SNRPN Polyclonal Antibody is a highly specific and reliable tool for studying the role of epigenetics in various biological processes. This antibody targets the SNRPN protein, which plays a crucial role in gene expression and is associated with several neurodevelopmental disorders.
The SNRPN protein is a key component of the SNURF-SNRPN complex, which is involved in regulating gene expression through epigenetic mechanisms. This complex is essential for proper brain development and function, making it an important target for research in the field of neurobiology. The Anti-SNRPN Polyclonal Antibody binds specifically to the SNRPN protein, allowing for the detection and analysis of its expression levels.
This antibody is primarily used in immunohistochemistry (IHC) and western blotting applications to study the expression of SNRPN in various tissues and cell lines. It is also suitable for use in other techniques such as immunofluorescence and flow cytometry.
The Anti-SNRPN Polyclonal Antibody has been successfully used in various research studies, including the investigation of SNRPN expression in neurodevelopmental disorders such as Prader-Willi syndrome and Angelman syndrome. It has also been used in studies exploring the role of SNRPN in neuronal development and function.
With its high specificity and sensitivity, this antibody has been cited in numerous publications and has been validated by independent research groups, making it a trusted tool for epigenetic research.
In conclusion, the Anti-SNRPN Polyclonal Antibody is a valuable resource for scientists studying the role of epigenetics in neurobiology. Its ability to specifically target the SNRPN protein and its proven efficacy in various research applications make it an essential tool for understanding the complex mechanisms of gene expression. Order now and take your epigenetic research to the next level.
ProteoGenix catalogue number ARO-A22065. For research use only.
Target: Small nuclear ribonucleoprotein-associated protein N; snRNP-N; Sm protein D; Sm-D; Sm protein N; Sm-N; SmN; Tissue-specific-splicing protein; SNRPN; HCERN3; SMN; Clonality: Polyclonal Antibody; Applications: ELISA, IHC.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| Small nuclear ribonucleoprotein-associated protein N; snRNP-N; Sm protein D; Sm-D; Sm protein N; Sm-N; SmN; Tissue-specific-splicing protein; SNRPN; HCERN3; SMN |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
